- Home
- TLSA vs APUR Comparison
TLSA vs APUR Comparison
Compare TLSA & APUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSA | APUR |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.1M | 146.9M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | TLSA | APUR |
|---|---|---|
| Price | $0.86 | $10.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 687.3K | 335.9K |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $9.90 |
| 52 Week High | $2.35 | $10.04 |
Technical Indicators
Market Signals| Indicator | TLSA | APUR |
|---|---|---|
| Relative Strength Index (RSI) | 32.91 | 78.31 |
| Support Level | N/A | $9.90 |
| Resistance Level | $1.20 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 12.73 | 87.50 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
About APUR Aperture AC Class A Ordinary Shares
Aperture AC is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.